139 related articles for article (PubMed ID: 38760405)
1. Nucleobindin 2 inhibits senescence in gastric carcinoma.
Ishibashi Y; Itoh T; Oguri Y; Hashimura M; Yokoi A; Matsumoto T; Harada Y; Fukagawa N; Hayashi M; Ono M; Kusano C; Saegusa M
Sci Rep; 2024 May; 14(1):11261. PubMed ID: 38760405
[TBL] [Abstract][Full Text] [Related]
2. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.
Ren L; Bao D; Wang L; Xu Q; Xu Y; Shi Z
J Cell Mol Med; 2022 Oct; 26(19):4986-4994. PubMed ID: 36065769
[TBL] [Abstract][Full Text] [Related]
3. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
[TBL] [Abstract][Full Text] [Related]
4. Nucleobindin-2 Promotes the Growth and Invasion of Glioblastoma.
Liu QJ; Lv JX; Liu J; Zhang XB; Wang LB
Cancer Biother Radiopharm; 2019 Nov; 34(9):581-588. PubMed ID: 31697592
[No Abstract] [Full Text] [Related]
5. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
Qi Q; Sun Y; Yang Y; Liu Y
Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
[TBL] [Abstract][Full Text] [Related]
6. MiR-30a-5p inhibits proliferation, migration and invasion of nasopharyngeal carcinoma cells by targeting NUCB2.
Li M; Wang Y; Zhao Q; Ma W; Liu J
Hum Exp Toxicol; 2021 Aug; 40(8):1274-1285. PubMed ID: 33567921
[TBL] [Abstract][Full Text] [Related]
7. Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule?
Kmiecik AM; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361082
[TBL] [Abstract][Full Text] [Related]
8. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
9. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.
Takagi K; Miki Y; Tanaka S; Hashimoto C; Watanabe M; Sasano H; Ito K; Suzuki T
Endocr J; 2016; 63(3):287-99. PubMed ID: 26842712
[TBL] [Abstract][Full Text] [Related]
10. Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.
Cho JM; Moon KT; Lee HJ; Shin SC; Choi JD; Kang JY; Yoo TK
Medicine (Baltimore); 2020 Mar; 99(13):e19597. PubMed ID: 32221080
[TBL] [Abstract][Full Text] [Related]
11. The effect and clinical significance of FN1 expression on biological functions of gastric cancer cells.
Zhou Y; Cao G; Cai H; Huang H; Zhu X
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):191-198. PubMed ID: 33040835
[TBL] [Abstract][Full Text] [Related]
12. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
[TBL] [Abstract][Full Text] [Related]
13. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of NUCB2 mRNA expression in prostate cancer.
Zhang H; Qi C; Li L; Luo F; Xu Y
J Exp Clin Cancer Res; 2013 Aug; 32(1):56. PubMed ID: 23958433
[TBL] [Abstract][Full Text] [Related]
15. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
16. Vinculin promotes gastric cancer proliferation and migration and predicts poor prognosis in patients with gastric cancer.
Zhang M; Liu P; Xu F; He Y; Xie X; Jiang X
J Cell Biochem; 2019 Aug; 120(8):14107-14115. PubMed ID: 30989694
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of cellular repressor of E1A-stimulated gene (CREG) in gastric cancer patients: a mechanism of proliferation and metastasis in cancer.
Xu L; Wang F; Liu H; Xu XF; Mo WH; Xia YJ; Wan R; Wang XP; Guo CY
Dig Dis Sci; 2011 Jun; 56(6):1645-55. PubMed ID: 21132365
[TBL] [Abstract][Full Text] [Related]
18. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
19. TGFβ1-Induced LncRNA UCA1 Upregulation Promotes Gastric Cancer Invasion and Migration.
Zuo ZK; Gong Y; Chen XH; Ye F; Yin ZM; Gong QN; Huang JS
DNA Cell Biol; 2017 Feb; 36(2):159-167. PubMed ID: 28075173
[TBL] [Abstract][Full Text] [Related]
20. circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2.
Xin R; Qu D; Xu H; Chen D
Cancer Gene Ther; 2021 Jun; 28(6):667-678. PubMed ID: 33110207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
